Procedure Guideline for Thyroid Scintigraphy
PDF
Cite
Share
Request
Review
VOLUME: 12 ISSUE: 1
P: 11 - 20
March 2026

Procedure Guideline for Thyroid Scintigraphy

Nucl Med Semin 2026;12(1):11-20
1. Celal Bayar Üniversitesi Tıp Fakültesi Nükleer Tıp Anabilim Dalı, Manisa, Türkiye
No information available.
No information available
Received Date: 02.02.2026
Accepted Date: 04.03.2026
Online Date: 31.03.2026
Publish Date: 31.03.2026
PDF
Cite
Share
Request

Abstract

Thyroid scintigraphy remains one of the cornerstone imaging modalities in nuclear medicine for the diagnosis and management of thyroid diseases, owing to its unique ability to simultaneously assess both the morphological structure and functional status of the thyroid gland. This guideline has been developed to ensure procedural standardization in thyroid scintigraphy, optimize image quality, and establish a common, consistent terminology for image interpretation. The guideline comprehensively addresses all stages of thyroid scintigraphy, ranging from patient preparation and radiopharmaceutical selection to imaging protocols and reporting criteria, based on current international literature and recent technological advances. In addition to conventional planar imaging techniques, the diagnostic contribution of a hybrid imaging modality such as single-photon emission computed tomography/computed tomography is emphasized due to its ability to integrate anatomical and functional information in selected clinical scenarios. This framework aims to serve as an evidence-based, up-to-date, and practical reference for nuclear medicine physicians, referring clinicians, and healthcare professionals, directly supporting clinical decision-making in routine practice.

Keywords:
Thyroid scintigraphy, SPECT/CT, nuclear medicine

References

1
Chung JK. Sodium iodide symporter: its role in nuclear medicine. J Nucl Med. 2002;43:1188-1200.
2
Ramos CD, Zantut Wittmann DE, Etchebehere EC, Tambascia MA, Silva CA, Camargo EE. Thyroid uptake and scintigraphy using 99mTc pertechnetate: standardization in normal individuals. Sao Paulo Med J. 2002;120:45-48.
3
Petranović Ovčariček P, Calderoni L, Campenni A, Fanti S, Giovanella L. Molecular imaging of thyroid and parathyroid diseases. Expert Rev Endocrinol Metab. 2024;19:317-333.
4
Giovanella L, Avram AM, Iakovou I, et al. EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy. Eur J Nucl Med Mol Imaging. 2019;46:2514-2525.
5
Giovanella L, Campennì A, Tuncel M, Petranović Ovčariček P. Integrated diagnostics of thyroid nodules. Cancers (Basel). 2024;16:311.
6
Novruzov E, Schmitt D, Mattes-György K, et al. Inter-reader agreement and additive benefit of SPECT or SPECT/CT modality with [ 99m Tc]Tc-pertechnetate scintigraphy imaging for the assessment of thyroid nodules in a tertiary care center. EJNMMI Rep. 2025;9:29.
7
Zhao H, Zheng C, Zhang H, et al. Diagnosis of thyroid disease using deep convolutional neural network models applied to thyroid scintigraphy images: a multicenter study. Front Endocrinol (Lausanne). 2023;14:1224191.
8
Qiao T, Liu S, Cui Z, et al. Deep learning for intelligent diagnosis in thyroid scintigraphy. J Int Med Res. 2021;49:300060520982842.
9
Bagheri S, Hajianfar G, Sabouri M, et al. Impact of field-of-view zooming and segmentation batches on radiomics features reproducibility and machine learning performance in thyroid scintigraphy. Clin Nucl Med. 2025;50:683-694.
10
Giovanella L, Avram A, Clerc J. Molecular imaging for thyrotoxicosis and thyroid nodules. J Nucl Med. 2021;62(Suppl 2):20S-25S.
11
Trimboli P, Bojunga J, Deandrea M, et al. Reappraising the role of thyroid scintigraphy in the era of TIRADS: a clinically-oriented viewpoint. Endocrine. 2024;85:1035-1040.
12
Sollmann L, Eveslage M, Danzer MF, et al. Additional value of pertechnetate scintigraphy to American College of Radiology Thyroid Imaging Reporting and Data Systems and European Thyroid Imaging Reporting and Data Systems for Thyroid Nodule Classification in euthyroid patients. Cancers (Basel). 2024;16:4184.
13
Abboud F, Alsiddig H, Haddad S, Daradkeh B, Bayat G, Haneyah F. Comparative cross-sectional study of ultrasonography and thyroid scintigraphy findings in adult patients with nodular goiter. Medicine (Baltimore). 2025;104:e42019.
14
Campennì A, Ovčariček PP, Giovanella L. On the rational use of thyroid scintigraphy in thyrotoxic patients in the age of integrated diagnostics. Eur J Nucl Med Mol Imaging. 2024;51:1682-1684.
15
Dizdarevic S, McCready VR, Skalonja M. Thyrotoxicosis is no insurance against thyroid cancer. Eur J Nucl Med Mol Imaging. 2024;51:1675-1677.
16
Bai QS, Shen LN, Wu CL, Tan J, Yang M, Xue XL. Imaging evaluation of amiodarone-induced thyroid dysfunction: ultrasonographic and radionuclide findings with clinical correlation. Quant Imaging Med Surg. 2025;15:12645-12654.
17
Amoako Y, Hammond E, Assasie-Gyimah A, Sarfo-Kantanka O. Thyroid scintigraphy in the management of benign thyroid disease. Ghana Med J. 2018;52:242.
18
Li WI, Chan TK, Ng KK, Kung BT. Predictive value of technetium-99m sodium pertechnetate thyroid scintigraphy in determining the permanence of congenital hypothyroidism. J Clin Imaging Sci. 2025;15:3.
19
Sumathy S, Palanivel S, Nagaraju K, et al. The role of neck ultrasonography and nuclear imaging in the diagnosis of congenital hypothyroidism. Indian J Endocrinol Metab. 2024;28:611-616.
20
Tsujioka Y, Yamada Y, Hasegawa T, Hashimoto M, Jinzaki M. Imaging findings of thyroid diseases in children. Clin Pediatr Endocrinol. 2025;34:89-104.
21
Taishan W, Alessa M, Alsaleh M, et al. Diagnostic utility of thyroid scan and ultrasound in managing thyroglossal cysts: a systematic literature review. J Med Life. 2025;18:517-525.
22
Aldawas G, Ragab S. A review of thyroid rests: from embryology to clinical management. Cureus. 2025;17:e95027.
23
Van den Bruel A, Drieskens P, Van Haecke H, et al. Graves’ disease in ectopic thyroid tissue: a scoping review and a case study. Eur Thyroid J. 2025;14:e250135.
24
Schenke SA, Görges R, Seifert P, Zimny M, Kreissl MC. Update on diagnosis and treatment of hyperthyroidism: ultrasonography and functional imaging. Q J Nucl Med Mol Imaging. 2021;65:102-112.
25
Ahn BC. Retrosternal goiter visualized on 99mTc pertechnetate SPECT/CT, but not on planar scintigraphy. Clin Nucl Med. 2016;41:e169-e170.
26
Ozdemir D, Cuhaci FN, Ozdemir E, et al. The role of postoperative Tc-99m pertechnetate scintigraphy in estimation of remnant mass and prediction of successful ablation in patients with differentiated thyroid cancer. Nucl Med Commun. 2016;37:640-645.
27
Aydin F, Sipahi M, Budak ES, et al. Role of Tc-99m pertechnetate for remnant scintigraphy, post-thyroidectomy, and serum thyroglobulin and antithyroglobulin antibody levels in the patients with differentiated thyroid cancer. Ann Nucl Med. 2016;30:60-67.
28
Chantadisai M, Kingpetch K. Usefulness of (99m)Tc-pertechnetate whole body scan with neck and chest SPECT/CT for detection of post-surgical thyroid remnant and metastasis in differentiated thyroid cancer patients. Ann Nucl Med. 2014;28:674-682.
29
Töre G, Özkılıç H, Kır M, Yüksel D. TNTD, tiroit sintigrafisi uygulama kılavuzu 2.0. Nuclear Med Seminars. 2015;1:41-43.
30
Silberstein EB, Alavi A, Balon HR, et al. The SNMMI practice guideline for therapy of thyroid disease with 131I 3.0. J Nucl Med. 2012;53:1633-1651.
31
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-. Sodium Iodide I 131. [Updated 2024 Nov 15]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK501563/
32
Canbaz Tosun F. Tiroit sintigrafisi. J Exp Clin Med. 2012;29:S289-S300.
33
Lassmann M, Treves ST; EANM/SNMMI Paediatric Dosage Harmonization Working Group. Paediatric radiopharmaceutical administration: harmonization of the 2007 EANM paediatric dosage card (version 1.5.2008) and the 2010 North American consensus guidelines. Eur J Nucl Med Mol Imaging. 2014;41:1036-1041.
34
Treves ST, Fahey FH, Ferrer Valencia V, et al. 2024 update of the North American Consensus guidelines for pediatric administered radiopharmaceutical activities. J Nucl Med Technol. 2025;53:193-197.
35
Balon HR, Silberstein EB, Meier DA, et al. Society of Nuclear Medicine procedure guideline for thyroid scintigraphy. Version 3.0. Reston (VA): Society of Nuclear Medicine; 2006.
36
Becker D, Charles ND, Dworkin H, et al. Procedure guideline for thyroid scintigraphy: 1.0. Society of Nuclear Medicine. J Nucl Med. 1996;37:1264-1266.
37
ACR-ACNM-SNMMI-SPR. ACR-ACNM-SNMMI-SPR Practice Parameter for the Performance of Scintigraphy and Uptake Measurements for Benign and Malignant Thyroid Disease. Revised 2024 (Resolution 16) [Internet]. Available from: https://gravitas.acr.org/PPTS/GetDocumentView?docId=60
38
Kristensen MH, Abrahamsen J, Thomsen HH. Intrathoracic goiter visualized on iodine-123 and technetium-99m single-photon emission computed tomography/computed tomography. World J Nucl Med. 2021;20:377-378.
39
Bozkurt MF, Demir H, Şanlı Y, et al. Tümör görüntülemede SPECT-BT hibrid görüntüleme uygulama kılavuzu. İstanbul: Türkiye Nükleer Tıp Derneği; 2010.
40
Serrano B, Amblard R, Beaumont T, et al. Quantitative analysis of 99mTc-pertechnetate thyroid uptake with a large-field CZT gamma camera: feasibility and comparison between SPECT/CT and planar acquisitions. EJNMMI Phys. 2023;10:45.
41
Kusić Z, Becker DV, Saenger EL, et al. Comparison of technetium-99m and iodine-123 imaging of thyroid nodules: correlation with pathologic findings. J Nucl Med. 1990;31:393-399.